on The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has submitted a Form 8.3 disclosure in relation to its interests in Spire Healthcare Group PLC. As of 17 October 2025, Vanguard holds 14,377,746 ordinary shares, representing 3.57% of the total shareholding. This position triggers the requirements under Rule 8.3 of the UK Takeover Code.
In addition to the shareholding, Vanguard reported a recent purchase of 2,344 shares at a price of 2.37 GBP per share. No cash-settled or stock-settled derivatives have been declared, nor other dealings or arrangements in relation to the securities of Spire Healthcare.
No other offerors or offerees are involved in this disclosure, and Vanguard confirmed no agreements or understandings regarding voting rights. This was declared on 20 October 2025 by contact Shawn Acker.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news